| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Galangin | Atherosclerosis | 1 | PM | 38293976 | 📋 | [Galangin inhibits oxidized low-density lipoprotein-induced angiogenic activity in human aortic endothelial cells by downregulating lncRNA H19] |
| Galangin | Cardiac Hypertrophy | 1 | PM | 35687907 | 📋 | Cardiorenal dysfunction and hypertrophy induced by renal artery occlusion are normalized by galangin treatment in rats |
| Galangin | Cardiotoxicity | 1 | PM | 37655750 | 📋 | Galangin attenuates doxorubicin-induced cardiotoxicity via activating nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation |
| Galangin | Cerebral Ischemia | 2 | PM | 27058522 | 📋 | Analysis of Potential Amino Acid Biomarkers in Brain Tissue and the Effect of Galangin on Cerebral Ischemia |
| Galangin | Cerebral Ischemia | 1 | PM | 23793526 | 📋 | Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia |
| Galangin | Cerebral Ischemia-Reperfusion | 1 | PM | 33127512 | 📋 | Galangin attenuated cerebral ischemia-reperfusion injury by inhibition of ferroptosis through activating the SLC7A11/GPX4 axis in gerbils |
| Galangin | Diabetic Cardiomyopathy | 1 | PM | 33752930 | 📋 | Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats |
| Galangin | Endothelial Dysfunction | 3 | PM | 37251824 | 📋 | Mitigation effect of galangin against aortic dysfunction and hypertrophy in rats with metabolic syndrome |
| Galangin | Endothelial Dysfunction | 1 | PM | 35321597 | 📋 | Galangin reduces vascular endothelial cell dysfunction via Heme oxygenase-1 signaling |
| Galangin | Endothelial Dysfunction | 2 | PM | 34543638 | 📋 | Galangin alleviates vascular dysfunction and remodelling through modulation of the TNF-R1, p-NF-κB and VCAM-1 pathways in hypertensive rats |
| Galangin | Hepatic Ischemia-Reperfusion | 1 | PM | 30481779 | 📋 | Galangin Alleviates Liver Ischemia-Reperfusion Injury in a Rat Model by Mediating the PI3K/AKT Pathway |
| Galangin | Hypertension | 2 | PM | 35687907 | 📋 | Cardiorenal dysfunction and hypertrophy induced by renal artery occlusion are normalized by galangin treatment in rats |
| Galangin | Hypertension | 1 | PM | 34543638 | 📋 | Galangin alleviates vascular dysfunction and remodelling through modulation of the TNF-R1, p-NF-κB and VCAM-1 pathways in hypertensive rats |
| Galangin | Ischemic Stroke | 2 | PM | 26537366 | 📋 | Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia |
| Galangin | Ischemic Stroke | 1 | PM | 23143152 | 📋 | By improving regional cortical blood flow, attenuating mitochondrial dysfunction and sequential apoptosis galangin acts as a potential neuroprotective agent after acute ischemic stroke |
| Galangin | Myocardial Fibrosis | 1 | PM | 33328989 | 📋 | Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats |
| Galangin | Myocardial Ischemia-Reperfusion | 2 | PM | 37637264 | 📋 | Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway |
| Galangin | Myocardial Ischemia-Reperfusion | 1 | PM | 36849103 | 📋 | Galangin alleviated myocardial ischemia-reperfusion injury by enhancing autophagic flux and inhibiting inflammation |
| Galangin | Myocarditis | 1 | PM | 33328989 | 📋 | Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats |
| Galangin | Vascular Disorders | 1 | PM | 34543638 | 📋 | Galangin alleviates vascular dysfunction and remodelling through modulation of the TNF-R1, p-NF-κB and VCAM-1 pathways in hypertensive rats |
| Galangin | Vascular Injury | 1 | PM | 36367287 | 📋 | Galangin inhibits neointima formation induced by vascular injury via regulating the PI3K/AKT/mTOR pathway |
| Galangin | Vasoconstriction | 1 | PM | 34231489 | 📋 | The Effect of Galangin on the Regulation of Vascular Contractility via the Holoenzyme Reactivation Suppressing ROCK/CPI-17 rather than PKC/CPI-17 |
